Saragovi HU - Search Results

1

HER2-mediated internalization of a targeted prodrug cytotoxic conjugate is dependent on the valency of the targeting ligand.

Guillemard V, Nedev HN, Berezov A, Murali R, Saragovi HU. Guillemard V, et al. Among authors: saragovi hu. DNA Cell Biol. 2005 Jun;24(6):350-8. doi: 10.1089/dna.2005.24.351. DNA Cell Biol. 2005. PMID: 15941387

2

A receptor that subserves reovirus binding can inhibit lymphocyte proliferation triggered by mitogenic signals.

Saragovi HU, Bhandoola A, Lemercier MM, Akbar GK, Greene MI. Saragovi HU, et al. DNA Cell Biol. 1995 Aug;14(8):653-64. doi: 10.1089/dna.1995.14.653. DNA Cell Biol. 1995. PMID: 7646812

3

A cell cycle regulating receptor is localized on cell surface and in nuclei of mitotically and meiotically dividing cells.

Roux E, Robaire B, Saragovi HU. Roux E, et al. Among authors: saragovi hu. DNA Cell Biol. 1998 Mar;17(3):239-47. doi: 10.1089/dna.1998.17.239. DNA Cell Biol. 1998. PMID: 9539104

4

A G1 cell cycle arrest induced by ligands of the reovirus type 3 receptor is secondary to inactivation of p21ras and mitogen-activated protein kinase.

Saragovi HU, Rebai N, Di Guglielmo GM, Macleod R, Sheng J, Rubin DH, Greene MI. Saragovi HU, et al. DNA Cell Biol. 1999 Oct;18(10):763-70. doi: 10.1089/104454999314908. DNA Cell Biol. 1999. PMID: 10541435

5

Taxane-antibody conjugates afford potent cytotoxicity, enhanced solubility, and tumor target selectivity.

Guillemard V, Saragovi HU. Guillemard V, et al. Among authors: saragovi hu. Cancer Res. 2001 Jan 15;61(2):694-9. Cancer Res. 2001. PMID: 11212270

6

Novel approaches for targeted cancer therapy.

Guillemard V, Saragovi HU. Guillemard V, et al. Among authors: saragovi hu. Curr Cancer Drug Targets. 2004 Jun;4(4):313-26. doi: 10.2174/1568009043332989. Curr Cancer Drug Targets. 2004. PMID: 15180497 Review.

7

Synthesis and evaluation of novel dipeptidyl benzoyloxymethyl ketones as caspase inhibitors.

Nedev HN, Klaiman G, LeBlanc A, Saragovi HU. Nedev HN, et al. Among authors: saragovi hu. Biochem Biophys Res Commun. 2005 Oct 21;336(2):397-400. doi: 10.1016/j.bbrc.2005.08.098. Biochem Biophys Res Commun. 2005. PMID: 16137654

8

Selective small molecule peptidomimetic ligands of TrkC and TrkA receptors afford discrete or complete neurotrophic activities.

Zaccaro MC, Lee HB, Pattarawarapan M, Xia Z, Caron A, L'Heureux PJ, Bengio Y, Burgess K, Saragovi HU. Zaccaro MC, et al. Among authors: saragovi hu. Chem Biol. 2005 Sep;12(9):1015-28. doi: 10.1016/j.chembiol.2005.06.015. Chem Biol. 2005. PMID: 16183026

9

Raft-dependent endocytosis of autocrine motility factor/phosphoglucose isomerase: a potential drug delivery route for tumor cells.

Kojic LD, Wiseman SM, Ghaidi F, Joshi B, Nedev H, Saragovi HU, Nabi IR. Kojic LD, et al. Among authors: saragovi hu. PLoS One. 2008;3(10):e3597. doi: 10.1371/journal.pone.0003597. Epub 2008 Oct 31. PLoS One. 2008. PMID: 18974847 Free PMC article.

10

Synthesis of biotinyl-TN14003, anti-HIV peptide amide.

Nedev H, Saragovi HU. Nedev H, et al. Among authors: saragovi hu. Adv Exp Med Biol. 2009;611:155-6. doi: 10.1007/978-0-387-73657-0_70. Adv Exp Med Biol. 2009. PMID: 19400137 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters